PGK1 Cancer Research Results
PGK1, Phosphoglycerate kinase 1: Click to Expand ⟱
| Source: |
| Type: |
Phosphoglycerate kinase 1 (PGK1) is the first critical enzyme to produce ATP in the glycolytic pathway. PGK1 is not only a metabolic enzyme but also a protein kinase, which mediates the tumor growth, migration and invasion through phosphorylation some important substrates.
PGK1 expression was shown to be significantly upregulated in multiple cancer tissues.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Lung, |
H1299 |
|
|
|
- |
in-vitro, |
Lung, |
H460 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
- |
in-vitro, |
Lung, |
H2030 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
Glycolysis↓, glucose consumption, lactate production, and ATP production were all strongly decreased by apigenin
lactateProd↓,
PGK1↓,
ALDOA↓,
GLUT1↓, Apigenin reduces GLUT1 expression levels.
ENO1↓,
ATP↓,
Casp9↑,
Casp3↑,
cl‑PARP↑, cleavage
PI3K/Akt↓,
HK1↓, HK1, HK2
HK2↓,
ROS↑, Apigenin causes oxidative stress leading to apoptosis. Because apoptotic signal transduction cascades involving caspase-9, -3 and PARP cleavage can be activated by increased ROS levels
Apoptosis↑,
eff↓, Cancer cells expressing high levels of GLUT1 are resistant to apigenin-induced apoptosis through metabolic compensation of glucose utilization.
NADPH↓, apigenin significantly decreased glucose utilization through suppression of GLUT1 expression, and consequently decreased NADPH production, which led to increased ROS levels.
PPP↓, inhibition of the PPP
TumVol↓, lower by 94%
Apoptosis↑,
Glycolysis↓, reduced levels of glycolysis intermediates.
PKM2↓,
PGK1↓,
ALDOAiso2↓,
Apoptosis↑,
ALDOA↓,
ENO2↓,
LDHA↓, LDH inhibitor
LDHB↓,
PFKP↓,
PGK1↓,
PGM1↓,
PGAM1↓,
OXPHOS↑, upregulation of 10 oxidative phosphorylation pathway proteins
TCA↑, upregulation of 8 tricarboxylic acid (TCA) cycle proteins
TumCP↓, synthetic application of vitamin C (VitC, 800 μM) and ATO (1 μM) significantly further inhibited the proliferation, migration, and invasion of OS cells and promoted cell apoptosis in vitro.
TumCMig↓,
TumCI↓,
eff↑, synthetic application of vitamin C (VitC, 800 μM) and ATO (1 μM) significantly further inhibited the proliferation,
Glycolysis↓, VitC and ATO directly suppresses the aerobic glycolysis of OS cells with the decreased production of pyruvate, lactate, and ATP via inhibiting the expression of the critical glycolytic genes (PGK1, PGM1, and LDHA).
lactateProd↓,
ATP↓,
PGK1↓,
PGM1↓,
LDHA↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
HK1↓, 1, OXPHOS↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 2,
Core Metabolism/Glycolysis ⓘ
ALDOA↓, 2, ALDOAiso2↓, 1, ENO1↓, 1, ENO2↓, 1, Glycolysis↓, 3, HK2↓, 1, lactateProd↓, 2, LDHA↓, 2, LDHB↓, 1, NADPH↓, 1, PFKP↓, 1, PGAM1↓, 1, PGK1↓, 4, PGM1↓, 2, PI3K/Akt↓, 1, PKM2↓, 1, PPP↓, 1, TCA↑, 1,
Cell Death ⓘ
Apoptosis↑, 3, Casp3↑, 1, Casp9↑, 1,
DNA Damage & Repair ⓘ
cl‑PARP↑, 1,
Migration ⓘ
TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1,
Drug Metabolism & Resistance ⓘ
eff↓, 1, eff↑, 1,
Functional Outcomes ⓘ
TumVol↓, 1,
Total Targets: 33
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: PGK1, Phosphoglycerate kinase 1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:460 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page